按需治疗与用于轻度胃食道逆流性疾病的质子抑制剂的持续维护治疗:一项前性随机多中心研究
Da Hyun Jung1, Young Hoon Youn2, Hye-Kyung Jung3
1Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
对于轻度胃食道逆流性疾病 (GERD),连续质子抑制剂 (PPI) 治疗对于初始维持比按需治疗更有效. 在持续治疗后,可以考虑在需要时进行治疗.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 对轻度胃食道逆流性疾病 (GERD) 的最佳维持治疗仍然不确定.
- 质子抑制剂 (PPI) 通常用于GERD管理.
研究的目的:
- 为了比较按需与持续的PPI维护治疗对非侵蚀性GERD或轻度侵蚀性食道炎的治疗.
- 为了确定最合适的初始维护策略轻度GERD.
主要方法:
- 在初始的PPI治疗后,有304名患有改善的GERD症状的患者被随机分类.
- 患者被分配到按需或持续的PPI维护,长达24周.
- 结果包括继续治疗的意愿,症状得分,生活质量和满意度.
主要成果:
- 持续治疗显示不愿继续治疗的比例较低 (36.1%),而不是按需治疗 (45.9%).
- 持续治疗组报告了明显更好的GERD症状控制,与健康有关的生活质量和整体满意度.
- 虽然按需治疗的处方成本较低,但持续治疗并没有提高血清胃素水平.
结论:
- 持续的PPI治疗似乎更适合于轻度GERD的初始维护.
- 在初始持续治疗期后,按需治疗可能是一个可行的选择.
- 建议进一步考虑降低到按需治疗.
更多相关视频
08:25Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
Published on: August 27, 2021
06:42Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
Published on: March 3, 2023
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
